The long-term complications of the inherited tubulopathies: an adult perspective

Pediatric Nephrology

Volumn 30, Issue 3, 2015, Pages 385-395

  Khosravi, Maryam ^a   Walsh, Stephen B ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Acid based; Adult nephrology; Electrolytes; Genetics; Inherited renal disease; Tubulopathy

Indexed keywords

ADULT; COMPLICATION; GENETICS; HUMAN; KIDNEY TUBULE DISORDER; TIME FACTOR;

ADULT; HUMANS; RENAL TUBULAR TRANSPORT, INBORN ERRORS; TIME FACTORS;

EID: 84894283861     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-014-2779-6     Document Type: Review

References (120)

1. Town M, Jean G, Cherqui S, Attard M, Forestier L, Whitmore SA, Callen DF, Gribouval O, Broyer M, Bates GP, van't Hoff W, Antignac C (1998) A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis. Nat Genet 18:319–324
2. Hsia D, Hsia H, Green S, Kay M, Gellis SS (1954) Amino-aciduria in galactosemia. AMA Am J Dis Child 88:458–465
3. Gentz J, Jagenburg R, Zetterström R (1965) Tyrosinemia: an inborn error of tyrosine metabolism with cirrhosis of the liver and multiple renal tubular defects (de Toni-Debré-Fanconi syndrome). J Pediatr 66:670–696
4. Morgan HG, Stewart WK, Lowe KG, Stowers JM, Johnstone JH (1962) Wilson’s disease and the Fanconi syndrome. QJM 31:361–384
5. Wallis LA, Engle RL Jr (1957) The adult Fanconi syndrome. II. Review of eighteen cases. Am J Med 22:13–23
6. Francis F, Hennig S, Korn B, Reinhardt R, de Jong P, Poustka A, Lehrach H, Rowe PSN, Goulding JN, Summerfield T, Mountford R, Read AP, Popowska E, Pronicka E, Davies KE, O’Riordan JLH, Econs MJ, Nesbitt T, Drezner MK, Oudet C, Pannetier S, Hanauer A, Storm TM, Meindl A, Lorenz B, Cagnoli B, Mohnike KL, Murken J, Meitinger BT (1995) A gene (PEX) with homologies to endopeptidases is mutated in patients with X–linked hypophosphatemic rickets. Nat Genet 11:130–136
7. Karim Z, Gérard B, Bakouh N, Alili R, Leroy C, Beck L, Silve C, Planelles G, Urena-Torres P, Grandchamp B, Friedlander G, Prié D (2008) NHERF1 mutations and responsiveness of renal parathyroid hormone. N Engl J Med 359:1128–1135
8. Amor B, Clemente-Coelho P, Roux C (1995) Adult-onset idiopathic phosphate diabetes. II. Time-course of clinical, laboratory test, and bone mineral density abnormalities under combined phosphate and calcitriol therapy. Rev Rhum Engl Ed 62:183–188
9. Seikaly MG, Quigley R, Baum M (2000) Effect of dipyridamole on serum and urinary phosphate in X-linked hypophosphatemia. Pediatr Nephrol 15:57–59
10. Quinlan C, Guegan K, Offiah A, Neill RO, Hiorns MP, Ellard S, Bockenhauer D, Hoff WV, Waters AM (2012) Growth in PHEX-associated X-linked hypophosphatemic rickets: the importance of early treatment. Pediatr Nephrol 27:581–588
11. Verge C, Lam A, Simpson J, Cowell CT, Howard NJ, Silink M (1991) Effects of therapy in X-linked hypophosphatemic rickets. N Engl J Med 325:1843–1848
12. Rivkees SA, el-Hajj-Fuleihan G, Brown EM, Crawford JD (1992) Tertiary hyperparathyroidism during high phosphate therapy of familial hypophosphatemic rickets. J Clin Endocrinol Metab 75:1514–1518
13. Lloyd SE, Pearce SHS, Fisher SE, Steinmeyer K, Schwappach B, Scheinman SJ, Harding B, Bolino A, Devoto M, Goodyer P, Rigden SP, Wrong O, Jentsch TJ, Craig IW, Thakker RV (1996) A common molecular basis for three inherited kidney stone diseases. Nature 379:445–449
14. Hoopes RR Jr, Shrimpton AE, Knohl SJ, Hueber P, Hoppe B, Matyus J, Simckes A, Tasic V, Toenshoff B, Suchy SF, Nussbaum RL, Scheinman SJ (2005) Dent disease with mutations in OCRL1. Am J Hum Genet 76:260–267
15. Wrong OM, Norden AGW, Feest TG (1994) Dent’s disease; a familial proximal renal tubular syndrome with low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, metabolic bone disease, progressive renal failure and a marked male predominance. QJM 87:473–493
16. Copelovitch L, Nash MA, Kaplan BS (2007) Hypothesis: Dent disease is an underrecognized cause of focal glomerulosclerosis. Clin J Am Soc Nephrol 2:914–918
17. Simon DB, Lu Y, Choate KA, Velazquez H, Al-Sabban E, Praga M, Casari G, Bettinelli A, Colussi G, Rodriguez-Soriano J, McCredie D, Milford D, Sanjad S, Lifton RP (1999) Paracellin-1, a renal tight junction protein required for paracellular Mg2+ resorption. Science 285:103–106
18. Hou J, Renigunta A, Konrad M, Gomes AS, Schneeberger EE, Paul DL, Waldegger S, Goodenough DA (2008) Claudin-16 and claudin-19 interact and form a cation-selective tight junction complex. J Clin Invest 118:619–628
19. Rodríguez-Soriano J, Vallo A (1994) Pathophysiology of the renal acidification defect present in the syndrome of familial hypomagnesaemia-hypercalciuria. Pediatr Nephrol 8:431–435
20. Praga M, Vara J, González-Parra E, Andrés A, Alamo C, Araque A, Ortiz A, Rodicio JL (1995) Familial hypomagnesemia with hypercalciuria and nephrocalcinosis. Kidney Int 47:1419–1425
21. Konrad M, Schaller A, Seelow D, Pandey AV, Waldegger S, Lesslauer A, Vitzthum H, Suzuki Y, Luk JM, Becker C, Schlingmann KP, Schmid M, Rodriguez-Soriano J, Ariceta G, Cano F, Enriquez R, Juppner H, Bakkaloglu SA, Hediger MA, Gallati S, Neuhauss SC, Nurnberg P, Weber S (2006) Mutations in the tight-junction gene claudin 19 (CLDN19) are associated with renal magnesium wasting, renal failure, and severe ocular involvement. Am J Hum Genet 79:949–957
22. Simon DB, Karet FE, Hamdan JM, DiPietro A, Sanjad SA, Lifton RP (1996) Bartter’s syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na–K–2CI cotransporter NKCC2. Nat Genet 13:183–188
23. Simon DB, Karet FE, Rodriguez-Soriano J, Hamdan JH, DiPietro A, Trachtman H, Sanjad SA, Lifton RP (1996) Genetic heterogeneity of Barter’s syndrome revealed by mutations in the K + channel, ROMK. Nat Genet 14:152–156
24. Simon DB, Bindra RS, Mansfield TA, Nelson-Williams C, Mendonca E, Stone R, Schurman S, Nayir A, Alpay H, Bakkaloglu A, Rodriguez-Soriano J, Morales JM, Sanjad SA, Taylor CM, Pilz D, Brem A, Trachtman H, Griswold W, Richard GA, John E, Lifton RP (1997) Mutations in the chloride channel gene, CLCNKB, cause Bartter’s syndrome type III. Nat Genet 17:171–178
25. Estévez R, Boettger T, Stein V, Birkenhäger R, Otto E, Hildebrandt F, Jentsch TJ (2001) Barttin is a Cl- channel β-subunit crucial for renal Cl- reabsorption and inner ear K + secretion. Nature 414:558–561
26. Watanabe S, Fukumoto S, Chang H, Takeuchi Y, Hasegawa Y, Okazaki R, Chikatsu N, Fujita T (2002) Association between activating mutations of calcium-sensing receptor and Bartter’s syndrome. Lancet 360:692–694
27. Bockenhauer D, Feather S, Stanescu HC, Bandulik S, Zdebik AA, Reichold M, Tobin J, Lieberer E, Sterner C, Landoure G, Arora R, Sirimanna T, Thompson D, Cross JH, van't Hoff W, Al Masri O, Tullus K, Yeung S, Anikster Y, Klootwijk E, Hubank M, Dillon MJ, Heitzmann D, Arcos-Burgos M, Knepper MA, Dobbie A, Gahl WA, Warth R, Sheridan E, Kleta R (2009) Epilepsy, ataxia, sensorineural deafness, tubulopathy, and KCNJ10 mutations. N Engl J Med 360:1960–1970
28. Cortesi C, Lava SAG, Bettinelli A, Tammaro F, Giannini O, Caiata-Zufferey M, Bianchetti MG (2010) Cardiac arrhythmias and rhabdomyolysis in Bartter–Gitelman patients. Pediatr Nephrol 25:2005–2008
29. Malafronte C, Borsa N, Tedeschi S, Syrèn ML, Stucchi S, Bianchetti MG, Achilli F, Bettinelli A (2004) Cardiac arrhythmias due to severe hypokalemia in a patient with classic Bartter disease. Pediatr Nephrol 19:1413–1415
30. Cortesi C, Bettinelli A, Emma F, Fischbach M, Bertolani P, Bianchetti MG (2005) Severe syncope and sudden death in children with inborn salt-losing hypokalaemic tubulopathies. Nephrol Dial Transplant 20:1981–1983
31. Foglia PE, Bettinelli A, Tosetto C, Cortesi C, Crosazzo L, Edefonti A, Bianchetti MG (2004) Cardiac work up in primary renal hypokalaemia-hypomagnesaemia (Gitelman syndrome). Nephrol Dial Transplant 19:1398–1402
32. Scognamiglio R, Negut C, Calo LA (2007) Aborted sudden cardiac death in two patients with Bartter’s/Gitelman’s syndromes. Clin Nephrol 67:193–197
33. Scognamiglio R, Calò LA, Negut C, Coccato M, Mormino P, Pessina AC (2008) Myocardial perfusion defects in Bartter and Gitelman syndromes. Eur J Clin Investig 38:888–895
34. Calo L, Scognamiglio R, Nistri S, Palisi M, Miorelli M, Zerbo F, Cantaro S, Antonello A, Fasoli G, D'Angelo A (1997) Evidence of myocardial dysfunction in Bartter’s syndrome. Am J Nephrol 17:124–127
35. van der Loos TM (1986) Profound hypokalemia with rhabdomyolysis in Bartter’s syndrome. JAMA 256:2518–2518
36. Nishihara G, Higashi H, Matsuo S, Yasunaga C, Sakemi T, Nakamoto M (1998) Acute renal failure due to hypokalemic rhabdomyolysis in Gitelman’s syndrome. Clin Nephrol 50:330–332
37. Gennari FJ (1998) Hypokalemia. N Engl J Med 339:451–458
38. von Vigier RO, Ortisi MT, Manna AL, Bianchetti MG, Bettinelli A (2010) Hypokalemic rhabdomyolysis in congenital tubular disorders: a case series and a systematic review. Pediatr Nephrol 25:861–866
39. Birkenhäger R, Otto E, Schürmann MJ, Vollmer M, Ruf EM, Maier-Lutz I, Beekmann F, Fekete A, Omran H, Feldmann D, Milford DV, Jeck N, Konrad M, Landau D, Knoers NV, Antignac C, Sudbrak R, Kispert A, Hildebrandt F (2001) Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure. Nat Genet 29:310–314
40. Schurman SJ, Perlman SA, Sutphen R, Campos A, Garin EH, Cruz DN, Shoemaker LR (2001) Genotype/phenotype observations in African Americans with Bartter syndrome. J Pediatr 139:105–110
41. Sato K, Ogata M (1995) A patients with chronic renal failure due to Bartter’s syndrome. Nihon Jinzo Gakkai Shi 37:404–409
42. Takahashi M, Yanagida N, Okano M, Ishizaki A, Meguro J, Kukita K, Tamaki T, Yonekawa M, Kawamura A, Yokoyama T (1996) A first report: living related kidney transplantation on a patient with Bartter’s syndrome. Transplant Proc 28:1588
43. Vaisbich MH, Fujimura MD, Koch VH (2004) Bartter syndrome: benefits and side effects of long-term treatment. Pediatr Nephrol 19:858–863
44. Bryan GT, MacCardle RC, Bartter FC (1966) Hyperaldosteronism, hyperplasia of the juxtaglomerular complex, normal blood pressure, and dwarfism: report of a case. Pediatrics 37:43–50
45. Blasi ER, Rocha R, Rudolph AE, Blomme EA, Polly ML, McMahon EG (2003) Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats. Kidney Int 63:1791–1800
46. Huang Y, Wongamorntham S, Kasting J, McQuillan D, Owens RT, Yu L, Noble NA, Border W (2006) Renin increases mesangial cell transforming growth factor-β1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms. Kidney Int 69:105–113
47. Gilbert RE, Cox A, Wu LL, Allen TJ, Hulthen UL, Jerums G, Cooper ME (1998) Expression of transforming growth factor-beta1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: effects of ACE inhibition. Diabetes 47:414–422
48. Walsh SB, Unwin E, Vargas-Poussou R, Houillier P, Unwin R (2011) Does hypokalaemia cause nephropathy? An observational study of renal function in patients with Bartter or Gitelman syndrome. QJM 104:939–944
49. Yamazaki H, Nozu K, Narita I, Nagata M, Nozu Y, Fu XJ, Matsuo M, Iijima K, Gejyo F (2009) Atypical phenotype of type I Bartter syndrome accompanied by focal segmental glomerulosclerosis. Pediatr Nephrol 24:415–418
50. Bockenhauer D, Cruwys M, Kleta R, Halperin LF, Wildgoose P, Souma T, Nukiwa N, Cheema-Dhadli S, Chong CK, Kamel KS, Davids MR, Halperin ML (2008) Antenatal Bartter’s syndrome: why is this not a lethal condition? QJM 101:927–942
51. Bockenhauer D, Bichet DG (2013) Inherited secondary nephrogenic diabetes insipidus: concentrating on humans. Am J Physiol Renal Physiol 304:F1037–F1042
52. Sayer JA, Pearce SHS (2001) Diagnosis and clinical biochemistry of inherited tubulopathies. Ann Clin Biochem 38:459–470
53. Alon US, Kaplan RA, Gratny LL, Nichols MA (1996) Histological long-term outcome of furosemide-induced nephrocalcinosis in the young rat. Pediatr Nephrol 10:191–194
54. Pope JCI, Trusler LA, Klein AM, Walsh WF, Yared A, Brock JW 3rd (1996) The natural history of nephrocalcinosis in premature infants treated with loop diuretics. J Urol 156:709–712
55. Smilde T, Haverman J, Schipper P, Hermus AR, van Liebergen FJ, Jansen JL, Kloppenborg PW, Koolen MI (1994) Familial hypokalemia/hypomagnesemia and chondrocalcinosis. J Rheumatol 21:1515–1519
56. Cobeta-Garcia JC, Gascón A, Iglesias E, Estopiñán V (1998) Chondrocalcinosis and Gitelman’s syndrome. A new association? Ann Rheum Dis 57:748–749
57. Marchini G, Tosi R, Parolini B, Castagna G, Zarbin M (1998) Choroidal calcification in Bartter syndrome. Am J Ophthalmol 126:727–729
58. Honavar SG, Shields CL, Demirci H, Shields JA (2001) Sclerochoroidal calcification: clinical manifestations and systemic associations. Arch Ophthalmol 119:833–840
59. Sun H, Demirci H, Shields CL, Shields JA (2005) Sclerochoroidal calcification in a patient with classic Bartter’s syndrome. Am J Ophthalmol 139:365–366
60. Berg CJVD, Tucker RM, Dousa TP (1982) Idiopathic hypercalciuria: hydrochlorothiazide decreases urinary calcium without altered renal response to parathyroid hormone. J Clin Endocrinol Metab 55:23–26
61. Ea H-K, Blanchard A, Dougados M, Roux C (2005) Chondrocalcinosis secondary to hypomagnesemia in Gitelman’s syndrome. J Rheumatol 32:1840–1842
62. Dvorak MM, Joussineau CD, Carter DH, Pisitkun T, Knepper MA, Gamba G, Kemp PJ, Riccardi D (2007) Thiazide diuretics directly induce osteoblast differentiation and mineralized nodule formation by interacting with a sodium chloride co-transporter in bone. J Am Soc Nephrol 18:2509–2516
63. Barry EL, Gesek FA, Kaplan MR, Hebert SC, Friedman PA (1997) Expression of the sodium-chloride cotransporter in osteoblast-like cells: effect of thiazide diuretics. Am J Physiol Cell Physiol 272:C109–C116
64. Wilson FH, Disse-Nicodème S, Choate KA, Ishikawa K, Nelson-Williams C, Desitter I, Gunel M, Milford DV, Lipkin GW, Achard JM, Feely MP, Dussol B, Berland Y, Unwin RJ, Mayan H, Simon DB, Farfel Z, Jeunemaitre X, Lifton RP (2001) Human hypertension caused by mutations in WNK kinases. Science 293:1107–1112
65. Boyden LM, Choi M, Choate KA, Nelson-Williams CJ, Farhi A, Toka HR, Tikhonova IR, Bjornson R, Mane SM, Colussi G, Lebel M, Gordon RD, Semmekrot BA, Poujol A, Välimäki MJ, De Ferrari ME, Sanjad SA, Gutkin M, Karet FE, Tucci JR, Stockigt JR, Keppler-Noreuil KM, Porter CC, Anand SK, Whiteford ML, Davis ID, Dewar SB, Bettinelli A, Fadrowski JJ, Belsha CW, Hunley TE, Nelson RD, Trachtman H, Cole TR, Pinsk M, Bockenhauer D, Shenoy M, Vaidyanathan P, Foreman JW, Rasoulpour M, Thameem F, Al-Shahrouri HZ, Radhakrishnan J, Gharavi AG, Goilav B, Lifton RP (2012) Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities. Nature 482:98–102
66. Louis-Dit-Picard H, Barc J, Trujillano D, Miserey-Lenkei S, Bouatia-Naji N, Pylypenko O, Beaurain G, Bonnefond A, Sand O, Simian C, Vidal-Petiot E, Soukaseum C, Mandet C, Broux F, Chabre O, Delahousse M, Esnault V, Fiquet B, Houillier P, Bagnis CI, Koenig J, Konrad M, Landais P, Mourani C, Niaudet P, Probst V, Thauvin C, Unwin RJ, Soroka SD, Ehret G, Ossowski S, Caulfield M, International Consortium for Blood Pressure (ICBP), Bruneval P, Estivill X, Froguel P, Hadchouel J, Schott JJ, Jeunemaitre X (2012) KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephron. Nat Genet 44:456–460
67. Paver W, Pauline G (1964) Hypertension and hyperpotassiumaemia without renal disease in a young male. Med J Aust 2:305–306
68. Mayan H, Vered I, Mouallem M, Tzadok-Witkon M, Pauzner R, Farfel Z (2002) Pseudohypoaldosteronism type II: marked sensitivity to thiazides, hypercalciuria, normomagnesemia, and low bone mineral density. J Clin Endocrinol Metab 87:3248–3254
69. Farfel A, Mayan H, Melnikov S, Holtzman EJ, Pinhas-Hamiel O, Farfel Z (2011) Effect of age and affection status on blood pressure, serum potassium and stature in familial hyperkalaemia and hypertension. Nephrol Dial Transplant 26:1547–1553
70. Brooks AM, Owens M, Sayer JA, Salzmann M, Ellard S, Vaidya B (2012) Pseudohypoaldosteronism type 2 presenting with hypertension and hyperkalaemia due to a novel mutation in the WNK4 gene. QJM 105:791–794
71. Mendes AI, Mascarenhas MR, Matos S, Sousa I, Ferreira J, Barbosa AP, Bicho M, Jordan P (2011) A WNK4 gene variant relates to osteoporosis and not to hypertension in the Portuguese population. Mol Genet Metab 102:465–469
72. Geven WB, Monnens LA, Willems HL, Buijs WC, ter Haar BG (1987) Renal magnesium wasting in two families with autosomal dominant inheritance. Kidney Int 31:1140–1144
73. Groenestege WM, Thébault S, van der Wijst J, van den Berg D, Janssen R, Tejpar S, van den Heuvel LP, van Cutsem E, Hoenderop JG, Knoers NV, Bindels RJ (2007) Impaired basolateral sorting of pro-EGF causes isolated recessive renal hypomagnesemia. J Clin Invest 117:2260–2267
74. Glaudemans B, van der Wijst J, Scola RH, Lorenzoni PJ, Heister A, van der Kemp AW, Knoers NV, Hoenderop JG, Bindels RJ (2009) A missense mutation in the Kv1.1 voltage-gated potassium channel–encoding gene KCNA1 is linked to human autosomal dominant hypomagnesemia. J Clin Invest 119:936–942
75. Schlingmann KP, Weber S, Peters M, Niemann Nejsum L, Vitzthum H, Klingel K, Kratz M, Haddad E, Ristoff E, Dinour D, Syrrou M, Nielsen S, Sassen M, Waldegger S, Seyberth HW, Konrad M (2002) Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nat Genet 31:166–170
76. Stuiver M, Lainez S, Will C, Terryn S, Günzel D, Debaix H, Sommer K, Kopplin K, Thumfart J, Kampik NB, Querfeld U, Willnow TE, Němec V, Wagner CA, Hoenderop JG, Devuyst O, Knoers NV, Bindels RJ, Meij IC, Müller D (2011) CNNM2, encoding a basolateral protein required for renal Mg2+ handling, is mutated in dominant hypomagnesemia. Am J Hum Genet 88:333–343
77. Karet FE, Finberg KE, Nelson RD, Nayir A, Mocan H, Sanjad SA, Rodriguez-Soriano J, Santos F, Cremers CW, Di Pietro A, Hoffbrand BI, Winiarski J, Bakkaloglu A, Ozen S, Dusunsel R, Goodyer P, Hulton SA, Wu DK, Skvorak AB, Morton CC, Cunningham MJ, Jha V, Lifton RP (1999) Mutations in the gene encoding B1 subunit of H + -ATPase cause renal tubular acidosis with sensorineural deafness. Nat Genet 21:84–90
78. Smith AN, Skaug J, Choate KA, Nayir A, Bakkaloglu A, Ozen S, Hulton SA, Sanjad SA, Al-Sabban EA, Lifton RP, Scherer SW, Karet FE (2000) Mutations in ATP6N1B, encoding a new kidney vacuolar proton pump 116-kD subunit, cause recessive distal renal tubular acidosis with preserved hearing. Nat Genet 26:71–75
79. Bruce LJ, Cope DL, Jones GK, Schofield AE, Burley M, Povey S, Unwin RJ, Wrong O, Tanner MJ (1997) Familial distal renal tubular acidosis is associated with mutations in the red cell anion exchanger (Band 3, AE1) gene. J Clin Invest 100:1693–1707
80. Singh PP, Pendse AK, Ahmed A, Ramavataram DV, Rajpurohit SK (1995) A study of recurrent stone formers with special reference to renal tubular acidosis. Urol Res 23:201–203
81. Norman ME, Feldman NI, Cohn RM, Roth KS, McCurdy DK (1978) Urinary citrate excretion in the diagnosis of distal renal tubular acidosis. J Pediatr 92:394–400
82. Wrong OM, Feest TG, Maciver AG (1993) Immune-related potassium-losing interstitial nephritis: a comparison with distal renal tubular acidosis. QJM 86:513–542
83. Phakdeekitcharoen B, Ruangraksa C, Radinahamed P (2004) Hypokalaemia and paralysis in the Thai population. Nephrol Dial Transplant 19:2013–2018
84. Sharma AP, Sharma RK, Kapoor R, Kornecki A, Sural S, Filler G (2007) Incomplete distal renal tubular acidosis affects growth in children. Nephrol Dial Transplant 22:2879–2885
85. Albright F, Burnett C (1946) Osteomalacia and late rickets; the various etiologies met in the United States with emphasis on that resulting from a specific form of renal acidosis, the therapeutic indications for each etiological sub-group, and the relationship between osteomalacia and Milkman’s syndrome. Medicine (Baltimore) 25:399–479
86. Wrong O, Henderson JE, Kaye M (2005) Distal renal tubular acidosis: alkali heals osteomalacia and increases net production of 1,25-dihydroxyvitamin D. Nephron Physiol 101:p72–p76
87. Domrongkitchaiporn S, Pongsakul C, Stitchantrakul W, Sirikulchayanonta V, Ongphiphadhanakul B, Radinahamed P, Karnsombut P, Kunkitti N, Ruang-raksa C, Rajatanavin R (2001) Bone mineral density and histology in distal renal tubular acidosis. Kidney Int 59:1086–1093
88. Weger W, Kotanko P, Weger M, Deutschmann H, Skrabal F (2000) Prevalence and characterization of renal tubular acidosis in patients with osteopenia and osteoporosis and in non‐porotic controls. Nephrol Dial Transplant 15:975–980
89. Khositseth S, Bruce LJ, Walsh SB, Bawazir WM, Ogle GD, Unwin RJ, Thong MK, Sinha R, Choo KE, Chartapisak W, Kingwatanakul P, Sumboonnanonda A, Vasuvattakul S, Yenchitsomanus P, Wrong O (2012) Tropical distal renal tubular acidosis: clinical and epidemiological studies in 78 patients. QJM 105:861–877
90. Khositseth S, Sirikanaerat A, Khoprasert S, Opastirakul S, Kingwatanakul P, Thongnoppakhun W, Yenchitsomanus PT (2008) Hematological abnormalities in patients with distal renal tubular acidosis and hemoglobinopathies. Am J Hematol 83:465–471
91. Vargas-Poussou R, Houillier P, Pottier NL, Stromph L, Loirat C, Baudouin V, Macher MA, Déchaux M, Ulinski T, Nobili F, Eckhart P, Novo R, Cailliez M, Salomon R, Nivet H, Cochat P, Tack I, Fargeot A, Bouissou F, Kesler GR, Lorotte S, Godefroid N, Layet V, Morin G, Jeunemaître X, Blanchard A (2006) Genetic investigation of autosomal recessive distal renal tubular acidosis: evidence for early sensorineural hearing loss associated with mutations in the ATP6V0A4 gene. J Am Soc Nephrol 17:1437–1443
92. Van den Ouweland AMW, Dreesen JCFM, Verdijk M, Knoers NV, Monnens LA, Rocchi M, van Oost BA (1992) Mutations in the vasopressin type 2 receptor gene (AVPR2) associated with nephrogenic diabetes insipidus. Nat Genet 2:99–102
93. Deen PM, Verdijk MA, Knoers NV, Wieringa B, Monnens LA, van Os CH, van Oost BA (1994) Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine. Science 264:92–95
94. Tank ES, Alexander SR, Craven RM (1980) Polyuric megalocystis. J Urol 124:692–694
95. Shalev H, Romanovsky I, Knoers NV, Lupa S, Landau D (2004) Bladder function impairment in aquaporin-2 defective nephrogenic diabetes insipidus. Nephrol Dial Transplant 19:608–613
96. Higuchi A, Kawamura T, Nakai H, Hasegawa Y (2002) Infrequent voiding in nephrogenic diabetes insipidus as a cause of renal failure. Pediatr Int 44:540–542
97. Holtzman EJ, Harris HW, Kolakowski LF, Guay-Woodford LM, Botelho B, Ausiello DA (1993) A molecular defect in the vasopressin V2-receptor gene causing nephrogenic diabetes insipidus. N Engl J Med 328:1534–1537
98. Zender HO, Ruedin P, Moser F, Bolle JF, Leski M (1992) Traumatic rupture of the urinary tract in a patient presenting nephrogenic diabetes insipidus associated with hydronephrosis and chronic renal failure: case report and review of the literature. Clin Nephrol 38:196–202
99. Earley LE, Orloff J (1962) The mechanism of antidiuresis associated with the administration of hydrochlorothiazide to patients with vasopressin-resistant diabetes insipidus. J Clin Invest 41:1988–1997
100. Libber S, Harrison H, Spector D (1986) Treatment of nephrogenic diabetes insipidus with prostaglandin synthesis inhibitors. J Pediatr 108:305–311
101. Nozue T, Uemasu F, Endoh H, Sako A, Takagi Y, Kobayashi A (1993) Intracranial calcifications associated with nephrogenic diabetes insipidus. Pediatr Nephrol 7:74–76
102. Wesche D, Deen PMT, Knoers NVAM (2012) Congenital nephrogenic diabetes insipidus: the current state of affairs. Pediatr Nephrol 27:2183–2204
103. Tohyama J, Inagaki M, Koeda T, Ohno K, Takeshita K (1993) Intracranial calcification in siblings with nephrogenic diabetes insipidus: CT and MRI. Neuroradiology 35:553–555
104. Schofer O, Beetz R, Kruse K, Rascher C, Schütz C, Bohl J (1990) Nephrogenic diabetes insipidus and intracerebral calcification. Arch Dis Child 65:885–887
105. Feldman BJ, Rosenthal SM, Vargas GA, Fenwick RG, Huang EA, Matsuda-Abedini M, Lustig RH, Mathias RS, Portale AA, Miller WL, Gitelman SE (2005) Nephrogenic syndrome of inappropriate antidiuresis. N Engl J Med 352:1884–1890
106. Decaux G, Vandergheynst F, Bouko Y, Parma J, Vassart G, Vilain C (2007) Nephrogenic syndrome of inappropriate antidiuresis in adults: high phenotypic variability in men and women from a large pedigree. J Am Soc Nephrol 18:606–612
107. Bockenhauer D, Penney MD, Hampton D, van't Hoff W, Gullett A, Sailesh S, Bichet DG (2012) A family with hyponatremia and the nephrogenic syndrome of inappropriate antidiuresis. Am J Kidney Dis 59:566–568
108. Clark BA, Shannon RP, Rosa RM, Epstein FH (1994) Increased susceptibility to thiazide-induced hyponatremia in the elderly. J Am Soc Nephrol 5:1106–1111
109. Geller DS, Rodriguez-Soriano J, Boado AV, Sschiffer S, Bayer M, Chang SS, Lifton RP (1998) Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I. Nat Genet 19:279–281
110. Geller DS, Zhang J, Zennaro M-C, Vallo-Boado A, Rodriguez-Soriano J, Furu L, Haws R, Metzger D, Botelho B, Karaviti L, Haqq AM, Corey H, Janssens S, Corvol P, Lifton RP (2006) Autosomal dominant pseudohypoaldosteronism type 1: mechanisms, evidence for neonatal lethality, and phenotypic expression in adults. J Am Soc Nephrol 17:1429–1436
111. Kerem E, Bistritzer T, Hanukoglu A, Hofmann T, Zhou Z, Bennett W, MacLaughlin E, Barker P, Nash M, Quittell L, Boucher R, Knowles M (1999) Pulmonary epithelial sodium-channel dysfunction and excess airway liquid in pseudohypoaldosteronism. N Engl J Med 341:156–162
112. Hanukoglu A, Bistritzer T, Rakover Y, Mandelberg A (1994) Pseudohypoaldosteronism with increased sweat and saliva electrolyte values and frequent lower respiratory tract infections mimicking cystic fibrosis. J Pediatr 125:752–755
113. Hansson JH, Nelson-Williams C, Suzuki H, Schild L, Shimkets R, Lu Y, Canessa C, Iwasaki T, Rossier B, Lifton RP (1995) Hypertension caused by a truncated epithelial sodium channel γ subunit: genetic heterogeneity of Liddle syndrome. Nat Genet 11:76–82
114. Vehaskari VM (2009) Heritable forms of hypertension. Pediatr Nephrol 24:1929–1937
115. Bogdanović R, Kuburović V, Stajić N, Mughal SS, Hilger A, Ninić S, Prijić S, Ludwig M (2012) Liddle syndrome in a Serbian family and literature review of underlying mutations. Eur J Pediatr 171:471–478
116. Tamura H, Schild L, Enomoto N, Matsui N, Marumo F, Rossier BC (1996) Liddle disease caused by a missense mutation of beta subunit of the epithelial sodium channel gene. J Clin Invest 97:1780–1784
117. Tapolyai M, Uysal A, Dossabhoy NR, Zsom L, Szarvas T, Lengvárszky Z, Fülöp T (2010) High prevalence of Liddle syndrome phenotype among hypertensive US veterans in northwest Louisiana. J Clin Hypertens 12:856–860
118. Baker E, Jeunemaitre X, Portal AJ, Grimbert P, Markandu N, Persu A, Corvol P, MacGregor G (1998) Abnormalities of nasal potential difference measurement in Liddle’s syndrome. J Clin Invest 102:10–14
119. Dave-Sharma S, Wilson RC, Harbison MD, Newfield R, Azar MR, Krozowski ZS, Funder JW, Shackleton CH, Bradlow HL, Wei JQ, Hertecant J, Moran A, Neiberger RE, Balfe JW, Fattah A, Daneman D, Akkurt HI, De Santis C, New MI (1998) Examination of genotype and phenotype relationships in 14 patients with apparent mineralocorticoid excess. J Clin Endocrinol Metab 83:2244–2254
120. Morineau G, Sulmont V, Salomon R, Fiquet-Kempf B, Jeunemaître X, Nicod J, Ferrari P (2006) Apparent mineralocorticoid excess: report of six new cases and extensive personal experience. J Am Soc Nephrol 17:3176–3184